The purpose of this study is to learn how well the combination of two medications (TAK-981 and pembrolizumab) works to treat Select Advanced or Metastatic Solid Tumors. In this study, we will also measure how your body reacts to the combination of medications.
COM_RESEARCHSTUDIES_DETAIL_HEADER_BASIC_CONTACT_4
North Carolina
Stergios Moschos
LCCC - Clinical Trials
Clinical or Medical
Interventional
Cancer (Melanoma)
22-2745
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
